2020
The association of statins for secondary prevention with progression to diabetes in patients with prediabetic state after coronary artery bypass graft surgery: A retrospective cohort study
Poorhosseini H, Tavolinejad H, Aminorroaya A, Soleimani H, Aasham O, Jalali A, Mohammadi A, Beigi S, Sadeghian S, Bagheri J, Tajdini M. The association of statins for secondary prevention with progression to diabetes in patients with prediabetic state after coronary artery bypass graft surgery: A retrospective cohort study. Journal Of Diabetes And Its Complications 2020, 34: 107713. PMID: 32900589, DOI: 10.1016/j.jdiacomp.2020.107713.Peer-Reviewed Original ResearchConceptsCoronary artery bypass graftingOccurrence of MACEPost-CABG patientsCumulative doseSecondary prevention of coronary artery diseaseSecondary preventionCoronary artery bypass graft surgeryPrevention of coronary artery diseaseArtery bypass graft surgeryFamily history of T2DMDoses of statinsTime of surgeryAssociation of statinsType 2 diabetes mellitusComposite of deathOccurrence of type 2 diabetes mellitusAdverse cardiovascular eventsBenefits of statinsBypass graft surgeryHistory of hypertensionHistory of T2DMArtery bypass graftingBody mass indexCoronary artery diseaseProgression to diabetes
2019
Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial
Pourhosseini H, Lashkari R, Aminorroaya A, Soltani D, Jalali A, Tajdini M. Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial. IJC Heart & Vasculature 2019, 22: 96-101. PMID: 30671535, PMCID: PMC6328087, DOI: 10.1016/j.ijcha.2018.12.003.Peer-Reviewed Original ResearchGroup AGroup BElective PCIPatients of group ACompared to group BAssociated with worse outcomesElective percutaneous coronary interventionHigh dose atorvastatinMedian follow-upElevated cardiac enzymesSensitivity troponin THigh-dose treatmentOccurrence of MACEPretreatment of patientsProportional hazards regression modelsMajor cardiovascular eventsHazards regression modelsPercutaneous coronary interventionDose atorvastatinCardiac enzymesDaily dosageStable anginaWorse outcomesCardiovascular eventsFollow-up